Search

everythinglearnresearchcommunity

for

Search:↓

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Targeting the AhR pathway may help treat alopecia areata.

Retinoic acid production and signaling in hair follicles are regulated by location and timing, affecting hair growth and cycling.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

QR678 Neo is more effective than PRP for hair growth and quality.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

ALX4 is crucial for normal craniofacial and hair development, with specific roles in different cell types.

Specific RNA patterns are linked to alopecia areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

RCS-01 cell therapy is safe and improves skin gene expression.

RIPK1 inhibitors might help prevent alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Two gene areas linked to male pattern baldness found, more research needed.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.